Published on Feb 13, 2013
The incidences of drug resistant strains are becoming more and more common while many manufactures have stepped back on the antibiotic development. These two factors have created a situation that has almost sent patients and physicians back to the pre-antibiotic era. Join Maryn McKenna author of "Superbug" as she explores the history and rise of multi-drug resistant MRSA.
What You Will Learn:
■ Review the rise of multi-drug resistant MRSA and CRE
■ Understand the complexities of MDROs in healthcare
■ Review the decline in antimicrobial development
■ Explore the structure of possible incentives to encourage new drugs
■ And much more!
Date: Thursday, February 28, 2013
Time: 2:00-3:00 pm ET